未找到相关数据
Update on lower-dose dasatinib 50 mg daily as frontline therapy in newly diagnosed chronic phase chronic myeloid leukemia (CML-CP).
被引：0
作者：
Naqvi, Kiran
Jabbour, Elias
Skinner, Jeffrey A.
Anderson, Kristin N.
Yilmaz, Musa
Jain, Nitin
Ferrajoli, Alessandra
Bose, Prithviraj
Thompson, Philip A.
Alvarado, Yesid
Takahashi, Koichi
Burger, Jan Andreas
Borthakur, Gautam
Estrov, Zeev
Pemmaraju, Naveen
Paul, Shilpa
Dellasala, Sara
Cortes, Jorge E.
Kantarjian, Hagop M.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7052
引用
收藏
页数：2
相关论文